FDA Thwarts Leo Pharma's US Launch Plans For Tralokinumab

Agency Issues CRL For Atopic Dermatitis Drug

Rhino
Tralokinumab path to approval blocked • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Dermatological

More from Therapeutic Category